Elanco Animal Health's Q4 Earnings Beat Expectation, FY22 Sales Guidance Trail Estimates

Elanco Animal Health Inc has reported Q4 EPS of $0.21 higher than $0.12 reported a year ago, surpassing analysts' view of $0.17.

Revenue was $1.11 billion, a decrease of 2% YY, unfavorably impacted by approximately $60 million of previously disclosed items that benefited Q4 FY20., beating the consensus of $1.10 billion.